Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00314
|
|||||
| Drug Name |
Betaine
|
|||||
| Synonyms |
Cystadane
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Inborn error of metabolism [ICD11: 5D2Z] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C5H11NO2
|
|||||
| Canonical SMILES |
C[N+](C)(C)CC(=O)[O-]
|
|||||
| InChI |
InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3
|
|||||
| InChIKey |
KWIUHFFTVRNATP-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 107-43-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 117.15 | Topological Polar Surface Area | 40.1 | ||
| Heavy Atom Count | 8 | Rotatable Bond Count | 1 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
0.5
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103345809
, 104294280
, 10503467
, 11537950
, 118309370
, 12075420
, 124441569
, 124893590
, 124893591
, 125311874
, 125337431
, 126522973
, 126645772
, 126675693
, 126676616
, 15297109
, 2165
, 24438624
, 24848564
, 24851128
, 24882186
, 24891511
, 24891663
, 3138572
, 3985
, 4422026
, 46475638
, 48415626
, 49893456
, 50123261
, 51072627
, 51091846
, 53789902
, 562302
, 57320071
, 57647743
, 57651874
, 58009761
, 588253
, 7978780
, 80573870
, 8145492
, 8150529
, 841599
, 85084160
, 85164915
, 85175607
, 87563491
, 91689506
, 93617181
|
|||||
| ChEBI ID |
CHEBI:17750
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | BGT1 | Transporter Info | Na(+)/Cl(-) betaine/GABA transporter | Substrate | [2] | |
| References | ||||||
| 1 | Betaine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult mice. Epilepsy Res. 2011 Jun;95(1-2):70-81. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.